Author:
Forrestal Brian J.,Case Brian C.,Yerasi Charan,Garcia-Garcia Hector M.,Waksman Ron
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Reference54 articles.
1. Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial;Pilgrim;Lancet,2014
2. Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial;Kandzari;Lancet,2017
3. Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial;Windecker;Circ Cardiovasc Interv,2015
4. Performance of the Orsiro hybrid drug-eluting stent in high-risk subgroups;Iglesias;Minerva Cardioangiol,2016
5. Orsiro - the first hybrid drug-eluting stent, opening up a new class of drug-eluting stents for superior patient outcomes;Tittelbach;Interventional Cardiology Review,2011
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献